Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly's Solpura Advisory Committee Could Hinge On Manufacturing Issues

This article was originally published in The Pink Sheet Daily

Executive Summary

Alnara, a Lilly subsidiary, says that its exocrine pancreatic insufficiency treatment is supported by two adequate and well-controlled trials, but FDA says that the product has changed so much that only one of them is relevant - and that one doesn't show strong enough efficacy.
Advertisement

Related Content

In A Manufacturing Dispute With FDA, Can A Sponsor Get Help From An Advisory Committee?
In A Manufacturing Dispute With FDA, Can A Sponsor Get Help From An Advisory Committee?
Sollpura's Future After No Vote From Panel Might Include More Trials, Adult Indication
Sollpura's Future After No Vote From Panel Might Include More Trials, Adult Indication
Lilly To Buy Alnara And Its Non-Porcine Pancreatic Enzyme Replacement Therapy
Rezield Needs Advantage Over Synagis, Advisory Cmte. Tells MedImmune
This Little Pig-Free Product Goes To Market? Alnara's High Hopes For A PERT
This Little Pig-Free Product Goes To Market? Alnara's High Hopes For A PERT

Topics

Advertisement
UsernamePublicRestriction

Register

PS071674

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel